Roche unit wins Fed Circ clash over blood clot treatment

21-09-2023

Muireann Bolger

Roche unit wins Fed Circ clash over blood clot treatment

lucarista / Shutterstock.com

Long-running legal dispute tackles questions of enablement and ‘undue experimentation’ | Federal Circuit says it is bound by SCOTUS’ findings in Amgen v Sanofi.


Baxalta, Genentech, Roche, Takeda, antibodies, haemophilia, enablement, patent, Federal Circuit, appeals

LSIPR